PL439884A1 - 4-[2,6-(diizopropylo)fenylo]-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne - Google Patents
4-[2,6-(diizopropylo)fenylo]-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne Download PDFInfo
- Publication number
- PL439884A1 PL439884A1 PL439884A PL43988421A PL439884A1 PL 439884 A1 PL439884 A1 PL 439884A1 PL 439884 A PL439884 A PL 439884A PL 43988421 A PL43988421 A PL 43988421A PL 439884 A1 PL439884 A1 PL 439884A1
- Authority
- PL
- Poland
- Prior art keywords
- thiosemicarbazide
- naphth
- diisopropyl
- phenyl
- methyl
- Prior art date
Links
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 title 1
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 abstract 2
- 150000003583 thiosemicarbazides Chemical class 0.000 abstract 2
- 101710120843 Indoleamine 2,3-dioxygenase 1 Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 abstract 1
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C337/00—Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C337/06—Compounds containing any of the groups, e.g. thiosemicarbazides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Przedmiotem zgłoszenia jest nowa pochodna tiosemikarbazydu, o wzorze ogólnym (1) przedstawionym na rysunku, będąca jednoczesnym inhibitorem ludzkiej topoizomerazy II oraz indoloamino-2,3-dioksygenazy 1 (IDO 1) Zgłoszenie obejmuje także sposób wytwarzania nowej pochodnej tiosemikarbazydu o wzorze ogólnym (1), oraz jej zastosowanie w leczeniu chorób nowotworowych.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL439884A PL243706B1 (pl) | 2021-12-17 | 2021-12-17 | 4-[2,6-(diizopropylo)fenylo]-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL439884A PL243706B1 (pl) | 2021-12-17 | 2021-12-17 | 4-[2,6-(diizopropylo)fenylo]-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL439884A1 true PL439884A1 (pl) | 2023-06-19 |
| PL243706B1 PL243706B1 (pl) | 2023-10-02 |
Family
ID=86944916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL439884A PL243706B1 (pl) | 2021-12-17 | 2021-12-17 | 4-[2,6-(diizopropylo)fenylo]-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL243706B1 (pl) |
-
2021
- 2021-12-17 PL PL439884A patent/PL243706B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL243706B1 (pl) | 2023-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA522432955B1 (ar) | Kras g12c مثبطات | |
| MX2024010045A (es) | Compuestos de quinazolina y uso de los mismos como inhibidores de proteinas mutantes kras. | |
| DK1565471T3 (da) | Quionolinylpyrazoler | |
| EA201690959A1 (ru) | Способ синтеза ингибитора индоламин-2,3-диоксигеназы | |
| CY1111721T1 (el) | Ακυλαμινοπυραζολια ως αναστολεις fgfr | |
| EA200501849A1 (ru) | Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ | |
| NO20061506L (no) | Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav | |
| BR0317717A (pt) | Composto, composição farmacêutica, uso de um composto, método para tratar um humano sofrendo de uma doença, e, processo para a preparação de um composto | |
| NO20085217L (no) | Effektive pyrimidinderivater i behandlingen av kreft | |
| EA200970932A1 (ru) | Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа | |
| GEP20135983B (en) | 1-benzyl-3-hydroxymethylindazole derivatives and usage therein treatment of diseases based on mcp-1, cx3cr1 and p40 expression | |
| SG11201900868XA (en) | Ido1 inhibitor and preparation method and application thereof | |
| SE0301232D0 (sv) | Novel use | |
| BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
| GEP20135913B (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereat treatment of diseases based on mcp-1 and cx3cr1 expression | |
| BR112023007912A2 (pt) | Formas cristalinas de um composto inibidor de kras g12c | |
| CO2022008690A2 (es) | Compuestos heterocíclicos como inhibidores de delta-5 desaturasa y métodos de uso | |
| MX2025002705A (es) | Isoquinolonas como inhibidores de pi3k | |
| WO2021164793A8 (zh) | 用作激酶抑制剂的化合物及其应用 | |
| SE0300098D0 (sv) | Use of cyclin D1 inhibitors | |
| CY1112638T1 (el) | Χρηση των παραγωγων ινδολιου ως ενεργοποιητες νurr-1 για την θεραπεια νοσου ραrκινsον | |
| EA202092766A1 (ru) | Конденсированные циклические производные пиразолона формамида, способ их получения, фармацевтическая композиция и их применение | |
| WO2021207682A3 (en) | Pi3 kinase inhibitors and uses thereof | |
| PL439883A1 (pl) | 4-(4-fenyloazofenylo)-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne | |
| PL439882A1 (pl) | 4-(4-fenyloazofenylo)-1-(2-nitrobenzylo)-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne |